{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:53:51Z","timestamp":1762005231852,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jamda.2020.06.047","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T22:21:43Z","timestamp":1596579703000},"page":"1636-1642.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antipsychotic Drugs and Hip Fracture: Associations Before and After the Initiation of Treatment"],"prefix":"10.1016","volume":"21","author":[{"given":"Jon","family":"Br\u00e4nnstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"L\u00f6vheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yngve","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2020.06.047_bib1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.euroneuro.2014.10.004","article-title":"High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort","volume":"24","author":"Taipale","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2020.06.047_bib2","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jamda.2020.06.047_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1017\/S1041610213000859","article-title":"Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings","volume":"25","author":"Gustafsson","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2020.06.047_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1192\/bjp.bp.114.162834","article-title":"Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons","volume":"207","author":"Koponen","year":"2015","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2020.06.047_bib5","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2020.06.047_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40268-019-0272-1","article-title":"Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA","volume":"19","author":"Phan","year":"2019","journal-title":"Drugs RD"},{"year":"2019","series-title":"Management of neuropsychiatric symptoms of dementia. 2018","author":"Press","key":"10.1016\/j.jamda.2020.06.047_bib7"},{"key":"10.1016\/j.jamda.2020.06.047_bib8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2020.06.047_bib9","doi-asserted-by":"crossref","first-page":"P753","DOI":"10.1016\/S2215-0366(19)30223-8","article-title":"Second-generation antipsychotic drugs and short-term somatic serious adverse events: A systematic review and meta-analysis","volume":"6","author":"Schneider-Thoma","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jamda.2020.06.047_bib10","first-page":"CD002852","article-title":"Haloperidol for agitation in dementia","volume":"2","author":"Lonergan","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2020.06.047_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2020.06.047_bib12","first-page":"CD003476","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease","volume":"1","author":"Ballard","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2020.06.047_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2020.06.047_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/aje\/kwp266","article-title":"The aftermath of hip fracture: Discharge placement, functional status change, and mortality","volume":"170","author":"Bentler","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2020.06.047_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-016-3881-3","article-title":"Use of antipsychotics increases the risk of fracture: A systematic review and meta-analysis","volume":"28","author":"Lee","year":"2017","journal-title":"Osteopor Int"},{"key":"10.1016\/j.jamda.2020.06.047_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/YIC.0000000000000221","article-title":"Antipsychotic drug exposure and risk of fracture: A systematic review and meta-analysis of observational studies","volume":"33","author":"Papola","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jamda.2020.06.047_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamapsychiatry.2018.3679","article-title":"Association between antidepressant drug use and hip fracture in older people before and after treatment initiation","volume":"76","author":"Brannstrom","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jamda.2020.06.047_bib18","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00198-019-05085-5","article-title":"Use of short-acting and long-acting hypnotics and the risk of fracture: A critical analysis of associations in a nationwide cohort","volume":"30","author":"Nordstrom","year":"2019","journal-title":"Osteopor Int"},{"key":"10.1016\/j.jamda.2020.06.047_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register-Opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.jamda.2020.06.047_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jamda.2020.06.047_bib21","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jamda.2020.06.047_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","article-title":"Time-dependent covariates in the Cox proportional-hazards regression model","volume":"20","author":"Fisher","year":"1999","journal-title":"Annu Rev Public Health"},{"year":"2011","series-title":"Flexible parametric survival analysis using Stata: Beyond the Cox model","author":"Royston","key":"10.1016\/j.jamda.2020.06.047_bib23"},{"key":"10.1016\/j.jamda.2020.06.047_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.publhealth.18.1.51","article-title":"Categorical data analysis in public health","volume":"18","author":"Preisser","year":"1997","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jamda.2020.06.047_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S1041610209008497","article-title":"Sex differences in the prevalence of behavioral and psychological symptoms of dementia","volume":"21","author":"Lovheim","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2020.06.047_bib27","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","author":"Radcliff","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020305697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861020305697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:21:38Z","timestamp":1761506498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861020305697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1525861020305697"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2020.06.047","relation":{},"ISSN":["1525-8610"],"issn-type":[{"type":"print","value":"1525-8610"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic Drugs and Hip Fracture: Associations Before and After the Initiation of Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2020.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}